PPH VanEck Pharmaceutical ETF

53

NASDAQ | ETF

Price
$87.11
Decreased by -0.34%
Dollar Volume (20D)
15.42 M
ADR%
0.93
Healthcare - 100.00%Basic Materials - 0.00%Communication Services - 0.00%Consumer Cyclicals - 0.00%Consumer Defensive - 0.00%Energy - 0.00%Financial Services - 0.00%Industrials - 0.00%Real Estate - 0.00%Technology - 0.00%Utilities - 0.00%
Healthcare - 100.00%
Basic Materials - 0.00%
Communication Services - 0.00%
Consumer Cyclicals - 0.00%
Consumer Defensive - 0.00%
Energy - 0.00%
Financial Services - 0.00%
Industrials - 0.00%
Real Estate - 0.00%
Technology - 0.00%
Utilities - 0.00%

Top 20 Holdings

Asset Name Sector Industry Weight
LLY Eli Lilly and Company Healthcare Drug Manufacturers - General 11.56%
NVO Novo Nordisk A/S Healthcare Biotechnology 9.7%
MRK Merck & Company Inc Healthcare Drug Manufacturers - General 6.45%
JNJ Johnson & Johnson Healthcare Drug Manufacturers - General 6.42%
AZN AstraZeneca PLC ADR Healthcare Drug Manufacturers - General 5.94%
ABBV AbbVie Inc Healthcare Drug Manufacturers - General 5.54%
NVS Novartis AG ADR Healthcare Drug Manufacturers - General 4.94%
MCK McKesson Corporation Healthcare Medical Distribution 4.8%
SNY Sanofi ADR Healthcare Drug Manufacturers - General 4.78%
ABC AmerisourceBergen Healthcare Medical Distribution 4.76%
H6D Haleon PLC null null 4.71%
GSK GlaxoSmithKline PLC ADR Healthcare Drug Manufacturers - General 4.48%
PFE Pfizer Inc Healthcare Drug Manufacturers - General 4.34%
TAK Takeda Pharmaceutical Co Ltd ADR Healthcare Drug Manufacturers - Specialty & Generic 4.12%
ZTS Zoetis Inc Healthcare Drug Manufacturers - Specialty & Generic 4.01%
BMY Bristol-Myers Squibb Company Healthcare Drug Manufacturers - General 3.9%
TEVA Teva Pharma Industries Ltd ADR Healthcare Drug Manufacturers - Specialty & Generic 2.85%
VTRS Viatris Inc Healthcare Drug Manufacturers - Specialty & Generic 1.87%
JAZZ Jazz Pharmaceuticals PLC Healthcare Biotechnology 1.03%
CTLT Catalent Inc Healthcare Drug Manufacturers - Specialty & Generic 0.96%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.